The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy Virtual 2020 | Updates on multiple myeloma management
Elena Zamagni, MD, PhD, University of Bologna, Bologna, Italy, outlines the latest advances in the management of multiple myeloma (MM), including newly diagnosed and relapsed/refractory patients. Additionally, Dr Zamagni shares her perspective on the future of MM therapy and where the field is expected to move. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
